title: Amphetamine-induced movement disorder.
abstract: Recreational use of amphetamines is common in Australia and New Zealand when compared with other developed nations. The clinical effects are variable because of the potential of these drugs to increase the proportion of different biogenic amines in the central nervous system (CNS). The substances affected are adrenaline, noradrenaline, serotonin and dopamine. Movement disorders represent one of the less common presentations of amphetamine toxicity but one that health care workers should be aware of nonetheless.
authors.affiliation: Department of Clinical Toxicology and Pharmacology, Newcastle Mater Hospital, and University of Newcastle, New South Wales, Australia. michael.downes@hnehealth.nsw.gov.au
authors.forename: Michael A
authors.initials: MA
authors.lastname: Downes
authors.forename: Ian M
authors.initials: IM
authors.lastname: Whyte
mesh_terms: D019969:Amphetamine-Related Disorders / Q000150:complications*; D000662:Amphetamines / Q000009:adverse effects* / Q000494:pharmacology; D002746:Chlorpromazine / Q000627:therapeutic use; D002819:Chorea / Q000139:chemically induced* / Q000503:physiopathology; D018492:Dopamine Antagonists / Q000627:therapeutic use; D006801:Humans; D020258:Neurotoxicity Syndromes / Q000209:etiology* / Q000503:physiopathology
chemical_list: D000662:Amphetamines; D018492:Dopamine Antagonists; D002746:Chlorpromazine